Symposium features disposable automated microkeratome, new epi-LASIK device

New Orleans-Refractive surgeons shared their experiences with the One Use-Plus microkeratome (Moria) for LASIK flaps as well as clinical trials using the new Epi-K device (Moria) for epi-LASIK, which is not yet available in the United States.

Charles Castoro, MD, of Havre de Grace, MD, noted that the One Use-Plus microkeratome is able to produce consistent, predictable LASIK flaps and offers clinical results comparable to the femtosecond laser.

"Because it is a single-use unit, it eliminates the risk of contamination. There are no problems with blade damage by inserting it into a head and disassembling and reassembling conditions," noted Dr. Castoro, who has been using the unit for 2 years on more than 2,000 eyes. "It also offers great visualization because of the plastic head. It is very predictable and produces excellent flap thickness."

Mark A. Swanson, MD, of Douglas, AZ, is pleased with the safety and efficacy of the Epi-K separator for epi-LASIK surgery. This fully automated system comes with a disposable head and ring and a metal blade with blunt edge. The Epi-K allows for mechanical cleavage of the epithelium from Bowman's membrane, producing a viable epithelial layer.

"More than 80% of the epithelial cells remain viable," Dr. Swanson said.

He noted that the edge and bed quality were excellent. Only 10% of patients experienced mild to moderate pain within the first 2 hours of surgery.

"In some LASIK patients, we noticed the same symptoms," he said.

Other presentations during the Moria symposium included:

• Barrie Soloway, MD, and his U.S. clinical studies with the Epi-K.

• Mark Whitten, MD, and his experience with the One Use microkeratome.

• Richard Duffey, MD, and his experience with creating thin LASIK flaps with the One Use device.

• A. John Kanellopoulos, MD, and his experience with microkeratome-assisted lamellar keratoplasties for keratoconus.